KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Depreciation & Amortization (CF) (2017 - 2024)

Historic Depreciation & Amortization (CF) for Gsk (GSK) over the last 7 years, with Q4 2015 value amounting to $1.4 billion.

  • Gsk's Depreciation & Amortization (CF) rose 952.94% to $1.4 billion in Q4 2015 from the same period last year, while for Sep 2016 it was $1.4 billion, marking a year-over-year increase of 952.94%. This contributed to the annual value of $1.3 billion for FY2018, which is 10.59% up from last year.
  • As of Q4 2015, Gsk's Depreciation & Amortization (CF) stood at $1.4 billion, which was up 952.94% from $1.2 billion recorded in Q4 2014.
  • In the past 5 years, Gsk's Depreciation & Amortization (CF) ranged from a high of $1.4 billion in Q4 2012 and a low of $33.0 million during Q4 2011
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $1.2 billion (2014), whereas its average is $1.0 billion.
  • Per our database at Business Quant, Gsk's Depreciation & Amortization (CF) tumbled by 9817.72% in 2011 and then surged by 413815.01% in 2012.
  • Over the past 5 years, Gsk's Depreciation & Amortization (CF) (Quarter) stood at $33.0 million in 2011, then soared by 4138.15% to $1.4 billion in 2012, then fell by 15.27% to $1.2 billion in 2013, then rose by 4.28% to $1.2 billion in 2014, then increased by 9.53% to $1.4 billion in 2015.
  • Its Depreciation & Amortization (CF) was $1.4 billion in Q4 2015, compared to $1.2 billion in Q4 2014 and $1.2 billion in Q4 2013.